A defining 2026 trend in the UK is the maturation of the FemTech sector, which has grown to represent a $1.6 billion niche within the national healthcare ecosystem. In 2026, the industry is shifting from basic "period tracking" to sophisticated biomarker-driven diagnostics, where apps are used in conjunction with at-home kits to test for everything from hormone imbalances to cervical cancer...